2002
DOI: 10.1021/jo026280d
|View full text |Cite
|
Sign up to set email alerts
|

The Synthesis of Azapeptidomimetic β-Lactam Molecules as Potential Protease Inhibitors

Abstract: Synthetic methods for the construction of a novel peptidomimetic structure are reported. The structure incorporates a beta-lactam and an azapeptide in a peptide backbone with the intention of generating rationally designed substrate-based protease inhibitors. The beta-lactam is formed by subjecting serine or threonine-azapeptides to Mitsunobu reaction conditions. Importantly, the azapeptidomimetic beta-lactam structure permits extended binding inhibition and the synthetic methods to create tetrapeptidomimetic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(13 citation statements)
references
References 59 publications
(27 reference statements)
0
13
0
Order By: Relevance
“…Malachowski [34] has recently reported the synthesis of a conceptually new azapeptidomimetic in which an N-amino-β-lactam moiety is incorporated in the peptide backbone. In particular, the authors synthesised the tetrapeptidomimetic 42 as a potential second-generation protease inhibitor.…”
Section: Azapeptidesmentioning
confidence: 99%
“…Malachowski [34] has recently reported the synthesis of a conceptually new azapeptidomimetic in which an N-amino-β-lactam moiety is incorporated in the peptide backbone. In particular, the authors synthesised the tetrapeptidomimetic 42 as a potential second-generation protease inhibitor.…”
Section: Azapeptidesmentioning
confidence: 99%
“…TLC was carried out on silica gel 60 F254 plates (Merck), and the spots were located with UV light. Methyl 2-(2-bromophenyl)-2-formylacetate (1a), [17] methyl 2-(2-bromo-5-methoxyphenyl)-2-formylacetate (1b), [17] tert-butyl 1-methylhydrazinecarboxylate (2b), [18] tert-butyl 1-(4-chlobenzyl)hydrazinecarboxylate (2f), [14] and tert-butyl 1-phenylhydrazinecarboxylate (2g) [15] were prepared in accordance with previously reported procedures.…”
Section: Methodsmentioning
confidence: 99%
“…Aza-amino acids confer unique conformational properties to the peptide backbone. The conformational effects of other variations, such as the incorporation of an aza group within -lactams 185 and aza-peptide Michael acceptors, 186 have not yet been fully explored. The conformational effects of other variations, such as the incorporation of an aza group within -lactams 185 and aza-peptide Michael acceptors, 186 have not yet been fully explored.…”
Section: Alicyclic Compoundsmentioning
confidence: 99%